OCT1 Genetic Variants Are Associated with Postoperative Morphine-related Adverse Effects in Children

Overview

Journal Pharmacogenomics

Specialties Genetics
Pharmacology

Date 2017 May 5

PMID 28470102

Citations 21

Authors

Rajiv Balyan

Xue Zhang

Vidya Chidambaran

Lisa J Martin

Tomoyuki Mizuno

Tsuyoshi Fukuda

Alexander A Vinks

Senthilkumar Sadhasivam

Affiliations

Soon will be listed here.

Abstract

Aim: Large interindividual variability in morphine pharmacokinetics (PK) could contribute to variability in morphine analgesia and adverse events. Respiratory depression (RD) and postoperative nausea and vomiting (PONV) are significant adverse drug response of intravenous morphine in the perioperative setting limiting its efficacy in achieving adequate surgical pain relief. OCT1 is a transporter in the liver that transports morphine from the bloodstream into hepatocytes. Earlier we reported association of genetic polymorphisms in OCT1 with morphine PK, and lower morphine clearance in Caucasian children as compared with African-American (AA) children. The aim of this study is to identify the association between common OCT1 genotypes affecting morphine's PK and clinically important postoperative morphine-related adverse outcomes.

Methods: After obtaining institutional review board (IRB) approval and informed consents, 311 children ages 6-15 years, American Society of Anesthesiologists' physical status 1 or 2 scheduled for tonsillectomy who received standard anesthetic, surgical and postoperative care were recruited. Clinical data collected included postoperative pain scores, total opioid use, incidence of PONV and RD. Four nonsynonymous SNPs of the OCT1 gene (rs12208357, rs34130495, rs72552763 and rs34059508) in each patient were genotyped using commercially available TaqMan assays. We investigated the genetic association of OCT1 with incidences of postoperative RD and PONV.

Results: Caucasian and AA children differed significantly in the incidence of obstructive sleep apnea (p < 0.001) and total morphine use (p = 0.028). There were incidences of prolonged post anesthesia care unit stay in 7% of Caucasian children, while no such incidences were observed for AA children (p = 0.05). OCT1 polymorphism rs12208357 was associated with high incidences of PONV and PONV leading to prolonged post anesthesia care unit stay (p < 0.05). A significant association was also found between rs72552763 GAT deletion and high incidence of RD (p = 0.007).

Conclusion: Children with certain OCT1 genotypes are associated with higher risk for RD and PONV following morphine administration leading to prolonged hospital stay. The OCT1 transporters' effects on morphine's PK could explain this association.

Citing Articles

Longitudinal assessment of SNPs rs72552763 and rs622342 in over HbA1c control among Mexican-Mestizo diabetic type 2 patients.

Ortega-Ayala A, de Andres F, LLerena A, Bartolo-Montiel C, Acosta-Altamirano G, Molina-Guarneros J Front Pharmacol. 2024; 15:1433519.

PMID: 39403148 PMC: 11471661. DOI: 10.3389/fphar.2024.1433519.

Institutional and Regional Variation in Opioid Prescribing for Hospitalized Infants in the US.

Keane O, Ourshalimian S, Lakshmanan A, Lee H, Hintz S, Nguyen N JAMA Netw Open. 2024; 7(3):e240555.

PMID: 38470421 PMC: 10936113. DOI: 10.1001/jamanetworkopen.2024.0555.

Organic cation transporters in psychiatric and substance use disorders.

Honan L, Fraser-Spears R, Daws L Pharmacol Ther. 2023; 253:108574.

PMID: 38072333 PMC: 11052553. DOI: 10.1016/j.pharmthera.2023.108574.

Genome-Wide Association Study Identifies Novel Candidate Variants Associated with Postoperative Nausea and Vomiting.

Nishizawa D, Morino R, Inoue R, Ohka S, Kasai S, Hasegawa J Cancers (Basel). 2023; 15(19).

PMID: 37835423 PMC: 10571790. DOI: 10.3390/cancers15194729.

A pilot study to identify pharmacogenomic and clinical risk factors associated with opioid related falls and adverse effects in older adults.

Sheikh S, Fernandez R, Smotherman C, Brailsford J, Langaee T, Velasquez E Clin Transl Sci. 2023; 16(11):2331-2344.

PMID: 37705211 PMC: 10651658. DOI: 10.1111/cts.13634.

References

Gorboulev V, Ulzheimer J, Akhoundova A, Karbach U, Quester S, Baumann C . Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 1997; 16(7):871-81. DOI: 10.1089/dna.1997.16.871. View

Tzvetkov M, Vormfelde S, Balen D, Meineke I, Schmidt T, Sehrt D . The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin Pharmacol Ther. 2009; 86(3):299-306. DOI: 10.1038/clpt.2009.92. View

Venkatasubramanian R, Fukuda T, Niu J, Mizuno T, Chidambaran V, Vinks A . ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children. Pharmacogenomics. 2014; 15(10):1297-309. PMC: 4190075. DOI: 10.2217/pgs.14.99. View

Saadatmand A, Tadjerpisheh S, Brockmoller J, Tzvetkov M . The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1. Biochem Pharmacol. 2012; 83(10):1427-34. DOI: 10.1016/j.bcp.2012.01.032. View

Sadhasivam S, Zhang X, Chidambaran V, Mavi J, Pilipenko V, Mersha T . Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects. Pharmacogenomics J. 2015; 15(5):436-42. PMC: 4492912. DOI: 10.1038/tpj.2014.79. View

Chervin R, Weatherly R, Garetz S, Ruzicka D, Giordani B, Hodges E . Pediatric sleep questionnaire: prediction of sleep apnea and outcomes. Arch Otolaryngol Head Neck Surg. 2007; 133(3):216-22. DOI: 10.1001/archotol.133.3.216. View

Tzvetkov M, Dos Santos Pereira J, Meineke I, Saadatmand A, Stingl J, Brockmoller J . Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol. 2013; 86(5):666-78. DOI: 10.1016/j.bcp.2013.06.019. View

Huwyler J, Drewe J, Klusemann C, Fricker G . Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium. Br J Pharmacol. 1996; 118(8):1879-85. PMC: 1909885. DOI: 10.1111/j.1476-5381.1996.tb15619.x. View

Giannoudis A, Wang L, Jorgensen A, Xinarianos G, Davies A, Pushpakom S . The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia. Blood. 2012; 121(4):628-37. DOI: 10.1182/blood-2012-01-405035. View

10.

Chervin , Hedger , Dillon , Pituch . Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000; 1(1):21-32. DOI: 10.1016/s1389-9457(99)00009-x. View

11.

Amphoux A, Vialou V, Drescher E, Bruss M, Mannoury la Cour C, Rochat C . Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006; 50(8):941-52. DOI: 10.1016/j.neuropharm.2006.01.005. View

12.

Sadhasivam S, Chidambaran V, Zhang X, Meller J, Esslinger H, Zhang K . Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics. Pharmacogenomics J. 2014; 15(2):119-26. DOI: 10.1038/tpj.2014.56. View

13.

Angst M, Lazzeroni L, Phillips N, Drover D, Tingle M, Ray A . Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology. 2012; 117(1):22-37. PMC: 3428265. DOI: 10.1097/ALN.0b013e31825a2a4e. View

14.

Tzvetkov M, Saadatmand A, Lotsch J, Tegeder I, Stingl J, Brockmoller J . Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol. Clin Pharmacol Ther. 2011; 90(1):143-50. DOI: 10.1038/clpt.2011.56. View

15.

Nies A, Koepsell H, Winter S, Burk O, Klein K, Kerb R . Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology. 2009; 50(4):1227-40. DOI: 10.1002/hep.23103. View

16.

Fecho K, Lunney A, Boysen P, Rock P, Norfleet E . Postoperative mortality after inpatient surgery: Incidence and risk factors. Ther Clin Risk Manag. 2009; 4(4):681-8. PMC: 2621384. DOI: 10.2147/tcrm.s2735. View

17.

Lin C, Tai Y, Huang M, Tsai Y, Hsu H, Tzen K . Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents. J Neurochem. 2010; 114(3):717-27. DOI: 10.1111/j.1471-4159.2010.06801.x. View

18.

Tzvetkov M, Saadatmand A, Bokelmann K, Meineke I, Kaiser R, Brockmoller J . Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron. Pharmacogenomics J. 2010; 12(1):22-9. DOI: 10.1038/tpj.2010.75. View

19.

Lotsch J, Dudziak R, Freynhagen R, Marschner J, Geisslinger G . Fatal respiratory depression after multiple intravenous morphine injections. Clin Pharmacokinet. 2006; 45(11):1051-60. DOI: 10.2165/00003088-200645110-00001. View

20.

Chidambaran V, Mavi J, Esslinger H, Pilipenko V, Martin L, Zhang K . Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents. Pharmacogenomics J. 2014; 15(3):255-62. PMC: 4406866. DOI: 10.1038/tpj.2014.59. View